VEGF is a known regulator of bone resorption (Zheng et al., 2013), while lysyl oxidase (LOX) release is driven by signaling of hypoxia inducible factors (HIF) to promote invading tumour cell colonisation and osteolysis at skeletal sites (Rankin et al., 2016). Here, LOX is linked to neoplasm.